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ClockBesides the master clock located in the suprachiasmatic nucleus (SCN) of the
brain, additional clocks are distributed across the central nervous system and
the body. The role of these ‘secondary’ clocks remains unclear. A new study
shows that the lack of an internal clock in histamine neurons profoundly
perturbs sleep.Antoine R. Adamantidis1,2
Circadian clocks have been widely
identified in cyanobacteria, fungi,
plants and animals. Indeed, most
biological processes — including the
sleep–wake cycle, blood pressure,
body temperature, the endocrine
system, liver metabolism,
etc. — displayw24-hour (i.e.,
circadian) periodic fluctuations. In
mammals, these circadian rhythms
are orchestrated by the hypothalamic
suprachiasmatic nucleus
(SCN) through autonomous
w24-hour oscillations of a
transcription/translation feedback
loop mechanism. And recently, the
cellular metabolic state, in particular
the redox state, has been shown to
exhibit a transcription-independent
autonomous circadian rhythm [1].
Besides the SCN, secondary clocks
have been identified throughout the
body; however, the importance of
these clocks in regulating biological
processes, in particular sleep–wake
behaviors, remains unclear.
In a study reported in a recent issue
of Current Biology [2], Yu and
colleagues investigated the
contribution of the internal clock within
histamine cells to the regulation of
sleep–wake cycle architecture and
cognitive processing. Histamine
neurons are exclusively located in the
tuberomamillary nucleus (TMN) of the
hypothalamus and represent an
important wake-promoting system of
the mammalian brain. The authors took
advantage of mouse genetic
engineering to generate HDC-DBmal1
knockout mice lacking the Bmal1 gene
selectively in cells producing histamine
decarboxylase (HDC), an enzyme
required for histamine biosynthesis.
At the circuit level, the histamine
system is classically viewed as one of
the major arousal-promoting systems
in the brain [3,4]. Histamine neurons are
tightly connected with the wake- and
sleep-promoting neural circuits in thebrain and show highest discharge rates
(<10 Hz) immediately after wake onset
and during attention, and lowest
activity during quiet wakefulness, just
before sleep [5]. A current hypothesis
regarding their arousal function posits
that histamine neurons project widely
throughout the central nervous system,
in particular wake-promoting brain
regions [4], where they activate
wake-promoting neurons from the
locus coeruleus, raphe nuclei, as well
as thalamus, basal forebrain, and
cortex [6,7]. In turn, TMN neurons also
project heavily to the sleep-active
ventrolateral preoptic nucleus (VLPO)
neurons, which reciprocally innervate
the TMN [8,9]. This was confirmed by
recent in vitro studies [3].
At the molecular level, the BMAL1
transcription factor forms a
heterodimer with CLOCK protein and
binds to E-box response elements in
the promoters of many genes including
the Period genes (Per1 and Per2), the
Cryptochrome genes (Cry1, Cry2, and
Cry3), and Rev-Erb (orphan nuclear
receptor gene). In turn, synthesized
PER, CRY and REV-ERB proteins are
transported back to the nucleus where
they repress Bmal1 expression.
The repressor complex also inhibits
Rev-Erb transcription, resulting in the
activation of Bmal1 transcription. This
negative feedback loop is terminated
by a drop in the protein levels of PER
and CRY, which results in a high level of
BMAL1 that further allows transcription
of the Per and Cry genes. The
expression of the Bmal1 gene peaks
during the dark phase, while
expression of Per, Cry, and other clock
control genes peak during the light
phase (i.e., anti-phase). Hence, this
molecular feedback loop controls
many physiological processes with
a period length of approximately
24 hours.
In the Yu et al. study [2], the authors
first confirmed that extracellular
histamine content in the brain is high
during periods of wakefulness, inparticular during high theta- or
gamma-range frequencies — the
hallmarks of wakefulness and attention
in mammals — while the lowest
concentration correlates with sleep
and delta-range oscillations, a marker
of sleep pressure [10]. Importantly, they
showed that genetic deletion of the
Bmal1 gene within histamine cells
disrupts the daily variation ofHDC gene
transcripts, which results in higherHDC
gene expression and elevated
histamine during the light phase of the
light/dark cycle, when mice are asleep.
This increase in histamine content in
the brain of HDC-DBmal1 mice
possibly results from elevated CRY1, or
reduced REV-ERB expression in these
mice. These results suggest a direct
link between a local transcription/
translation feedback clock and the
production and/or release of histamine
by TMN cells, the only source of
histamine in the brain.
In addition to clock-related
regulation of histamine synthesis and
degradation, its concentration in the
extracellular space depends on its
release by HDC neurons in the TMN
upon cellular activity. This latter point
has recently been investigated by
Williams and collaborators [3]. They
found that optogenetic activation of
histamine neuron terminals provokes
the release of histamine, which reduces
GABAergic input to TMN neurons
through H3 histamine receptors, while
increasing activity of GABA cells
through H1 histamine receptors that
inhibit sleep-promoting VLPO cells.
Collectively, these results suggest that
activation of histamine neurons during
wakefulness activate other TMN cells
and inhibit sleep-promoting neurons in
the VLPO [3]. In addition to releasing
histamine, histamine neurons
synthesize GABA — they express the
GABA-synthesizing enzyme GAD67
[11]. However, it’s unclear whether they
actually release GABA [12].
Surprisingly, Williams and colleagues
did not find any experimental evidence
of GABA release from histamine cells.
Collectively, these results suggest that
increased activity of histamine neurons
during wakefulness is responsible for
increased histamine content in the
brain during the active state. How the
persistence of histamine is regulated
through its degradation in the
extracellular space, possibly through a
topographically specific enzyme
activity, remains to be investigated but
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elevated histamine content in the brain
of HDC-DBmal1 knockout mice.
Importantly, this increase may also
result from an increased vesicular
release of histamine from histamine
neurons (the only source of histamine in
the mammalian brain), or an increase in
their firing discharges across the
sleep–wake cycle in this model.
The authors also found that the
steady increase of histamine content
during the light phase — when
nocturnal mice are mostly asleep— led
to a dramatic change of the animal’s
behavior including hyper-locomotion
and perturbed sleep. But surprisingly,
at light onset, HDC-DBmal1 mice have
a greater tendency to sleep than their
wild-type littermates due to an increase
in REM sleep duration and REM-sleep
theta oscillation (6–9 Hz) amplitude.
Interestingly, although their total
amount of NREM sleep is unchanged,
they are unable to maintain stable
sleep, as revealed by a strong NREM
sleep fragmentation. This impaired
NREM sleep quality is further
confirmed by a reduced delta
frequency band (0.5–4 Hz)
amplitude — a marker of sleep
intensity — during spontaneous sleep,
as well as during a sleep rebound
induced by an experimental sleep
deprivation procedure. This latter result
suggests that the lack of BMAL1, or
the subsequent increase of histamine,
strongly impaired sleep
homeostatic processes. At dark onset,
HDC-DBmal1 mice are more awake
and show prolonged wake episodes,
with increased theta and gamma
oscillations consistent with their
increased locomotor activity. Overall,
the ‘hyper-histaminergic’ phenotype of
HDC-DBmal1 mice is opposite to that
of mice lacking the HDC gene and
histamine (HDC knockout mice) [13]. In
contrast to HDC-DBmal1 mice that
showed fragmented sleep and
prolonged wakefulness, HDC knockout
mice showed a strong impairment of
arousal maintenance at dark onset,
when animals are normally active.
As mentioned, the increase of
NREM-to-REM sleep transitions and
the increased REM sleep duration seen
in the HDC-DBmal1 mouse are quite
surprising and contrast with the overall
hyperactive phenotype. The reasons
for these results might be multiple and
could result from, firstly, a possible
adaptation of the circadian molecular
machinery to the absence of afunctional BMAL1 molecule, secondly,
a secondary adaptation to the
disruption of histamine periodic
changes in the brain or high HDC
transcript levels after sleep deprivation
in HDC-DBmal1mice (while they return
to baseline level in control animals), or,
thirdly, altered histamine neuron
discharge across the sleep–wake cycle
in HDC-DBmal1mice. It is important to
note, however, that the in vitro
electrophysiological fingerprint of
histamine neurons remains
unchanged, suggesting that altered
activity of the histamine neurons does
not explain the phenotype. Future
investigations should investigate the
functional wiring of histamine cells with
other arousal centers in intact circuits
and their in vivo modulation of
sleep–wake states in wild-type and
HDC-DBmal1 mice.
Finally, the authors found that the
perturbations of sleep-wake states
seen in the knockout mice ultimately
impair learning and memory
processes. Importantly, in normal
sleep–wake cycle conditions, control
littermates and HDC-DBmal1 mice
performed the same in a novel object
recognition task. However, sleep
deprivation significantly impaired
performance in the knockout mice,
even after 17 hours of recovery sleep.
This result suggests that impaired
sleep recovery in HDC-DBmal1 mice
negatively impacts cognitive function
in this model. Interestingly, this is
consistent with another study of sleep
fragmentation using an optogenetically
induced sleep fragmentation to show
the importance of sleep architecture on
memory consolidation [14].
Since the absence of the Bmal1 gene
in the SCN renders animal arrhythmic
[15], but its selective deletion in HDC
cells does not, the authors conclude
that local BMAL1 expression in
histamine cells participates in the
fine-tuning of an adequate sleep–wake
balance, as well as sleep quality
imposed by the SCN. Besides the
importance of secondary clock(s) in the
brain, this study also reveals the
complexity of multi-mode
communication between brain cells in
controlling behavior, including the
sleep–wake cycle. For instance, the
local concentration of extracellular
histamine in the brain is precisely
regulated, and depends on its
biosynthesis, its release by histamine
neurons, and its degradation
pathways. Interestingly, some of thesepathways may be influenced by
topographically distinct mechanisms
and, therefore, expand the possible
modes of communication of histamine
neurons in the brain [16]. This is equally
relevant to other modulatory
systems of the brain releasing a
complex combination of transmitters
and modulators/peptides, as
recently shown for dopamine or
hypocretin/orexin neurons, as well as
neurons co-releasing GABA/Glutamate
[17–19]. Collectively these studies
point to the need for new tools to
measure neuromodulator/peptide
releasewith a high temporal and spatial
resolution in vivo in order to
differentiate their fast action from slow,
possibly circadian, fluctuation in
controlling behavior.
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